Cargando…

Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease

BACKGROUND AND AIMS: Metabolic-associated fatty liver disease (MAFLD) is a newly proposed terminology from 2020; yet, the applicability of conventional noninvasive fibrosis models is still unknown for it. We aimed to evaluate the performance of conventional noninvasive fibrosis scores in MAFLD. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xiaoning, Goh, George Boon-Bee, Huang, Jiaofeng, Wu, Yinlian, Wang, Mingfang, Kumar, Rahul, Lin, Su, Zhu, Yueyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396333/ https://www.ncbi.nlm.nih.gov/pubmed/36062270 http://dx.doi.org/10.14218/JCTH.2021.00311

Ejemplares similares

MAFLD Criteria May Overlook a Subtype of Patient with Steatohepatitis and Significant Fibrosis
por: Huang, Jiaofeng, et al.
Publicado: (2021)

Fatty liver disease reverses the obesity paradox in chronic kidney disease stages 3–5: A follow‐up study of NHANES III
por: Huang, Jiaofeng, et al.
Publicado: (2022)

MAFLD Criteria Guide the Subtyping of Patients with Fatty Liver Disease
por: Huang, Jiaofeng, et al.
Publicado: (2021)

Procalcitonin and Liver Disease: A Literature Review
por: Dong, Ruolin, et al.
Publicado: (2018)

Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease
por: Cheah, Mark CC, et al.
Publicado: (2017)

Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Wu, Yin-Lian, et al.
Publicado: (2021)

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease
por: Cichoż-Lach, Halina, et al.
Publicado: (2012)

Serum high-sensitive C-reactive protein is a simple indicator for all-cause among individuals with MAFLD
por: Huang, Jiaofeng, et al.
Publicado: (2022)

Is Toxoplasma gondii infection correlated with nonalcoholic fatty liver disease?- a population-based study
por: Huang, Jiaofeng, et al.
Publicado: (2018)

The Association between Meteorological Factors and the Prevalence of Acute-on-chronic Liver Failure: A Population-based Study, 2007–2016
por: Lin, Su, et al.
Publicado: (2019)

The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment
por: Zhang, Kai, et al.
Publicado: (2020)

Circadian Misalignment Rather Than Sleep Duration is Associated with MAFLD: A Population-Based Propensity Score-Matched Study
por: Weng, Zhiyuan, et al.
Publicado: (2021)

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Hong, Jian-Guo, et al.
Publicado: (2022)

Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients: A meta-analysis
por: Wu, Yinlian, et al.
Publicado: (2016)

Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease
por: Chang, Pik Eu, et al.
Publicado: (2018)

Reappraisal of fibrosis-4 index and non-alcoholic fatty liver disease fibrosis score for advanced fibrosis in average-risk population
por: Park, Huiyul, et al.
Publicado: (2022)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease
por: Alkhouri, Naim, et al.
Publicado: (2014)

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Lee, Tae Hoon, et al.
Publicado: (2013)

Syphilitic hepatitis: a case report and review of the literature
por: Huang, Jiaofeng, et al.
Publicado: (2019)

Authors response to correspondence regarding paper entitled Syphilitic hepatitis: a case report and review of the literature
por: Huang, Jiaofeng, et al.
Publicado: (2020)

Evaluating the global, regional, and national impact of syphilis: results from the global burden of disease study 2019
por: Chen, Tao, et al.
Publicado: (2023)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Antiviral Therapy in Chronic Hepatitis B With Mild Acute Exacerbation
por: Lin, Su, et al.
Publicado: (2017)

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Guan, Yong-Song
Publicado: (2014)

Performance of non-invasive fibrosis scores in non-alcoholic fatty liver disease with and without morbid obesity
por: Drolz, Andreas, et al.
Publicado: (2021)

Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease
por: Tapper, Elliot B., et al.
Publicado: (2014)

Non-Invasive Diagnostic Test for Advanced Fibrosis in Adolescents With Non-Alcoholic Fatty Liver Disease
por: Mosca, Antonella, et al.
Publicado: (2022)

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease
por: Younossi, Zobair M., et al.
Publicado: (2021)

Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver disease
por: Basheer, Maamon, et al.
Publicado: (2023)

Non-invasive fibrosis assessment in non-alcoholic fatty liver disease
por: Rios, Rafael S., et al.
Publicado: (2020)

Commentary on “Simple non-invasive biomarkers of advanced fibrosis in the evaluation of non-alcoholic fatty liver disease”
por: Kayadibi, Huseyin, et al.
Publicado: (2014)

Comparative Accuracy of Clinical Fibrosis Markers, Hepascore and Fibroscan® to Detect Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Bertot, Luis C., et al.
Publicado: (2023)

Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
por: Lee, Jun-Hyuk, et al.
Publicado: (2022)

Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Olteanu, Vasile-Andrei, et al.
Publicado: (2022)

Non-Invasive Evaluation of Cystic Fibrosis Related Liver Disease in Adults with ARFI, Transient Elastography and Different Fibrosis Scores
por: Karlas, Thomas, et al.
Publicado: (2012)

The role of non-invasive scores in determining the liver fibrosis in NAFLD and psoriatic patients
por: Neagoe, Carmen-Daniela, et al.
Publicado: (2020)

Non-invasive methods to evaluate liver fibrosis in patients with non-alcoholic fatty liver disease
por: Wang, Jincheng, et al.
Publicado: (2022)

Non‐invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease
por: Simbrunner, Benedikt, et al.
Publicado: (2020)

Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis
por: Chen, Vincent L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8j09451gua7iegem0bfucc854t